RT Conference Proceedings
T1 Adalimumab persistence and its biosimilar in inflammatory bowel disease: experience in a tertiary centre
A1 Cano, M. C. Fernandez
A1 Sanchez-Capilla, A. D.
A1 Martin-Rodriguez, M. M.
A1 Cabello-Tapia, M. J.
A1 Redondo-Cerezo, E.
PB Oxford univ press
SN 1873-9946
YR 2021
FD 2021-05-01
LK https://hdl.handle.net/10668/26285
UL https://hdl.handle.net/10668/26285
LA en
DS RISalud
RD Apr 17, 2025